- Home
- KRYS vs NVEI Comparison
KRYS vs NVEI Comparison
Compare KRYS & NVEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- NVEI
- Stock Information
- Founded
- KRYS 2015
- NVEI 2003
- Country
- KRYS United States
- NVEI Canada
- Employees
- KRYS N/A
- NVEI N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- NVEI
- Sector
- KRYS Health Care
- NVEI
- Exchange
- KRYS Nasdaq
- NVEI Nasdaq
- Market Cap
- KRYS 5.1B
- NVEI 4.7B
- IPO Year
- KRYS 2017
- NVEI 2021
- Fundamental
- Price
- KRYS $170.21
- NVEI $33.99
- Analyst Decision
- KRYS Strong Buy
- NVEI Hold
- Analyst Count
- KRYS 8
- NVEI 14
- Target Price
- KRYS $199.43
- NVEI $32.38
- AVG Volume (30 Days)
- KRYS 236.9K
- NVEI 865.5K
- Earning Date
- KRYS 11-04-2024
- NVEI 11-12-2024
- Dividend Yield
- KRYS N/A
- NVEI 1.18%
- EPS Growth
- KRYS N/A
- NVEI N/A
- EPS
- KRYS 1.77
- NVEI 0.16
- Revenue
- KRYS $241,519,000.00
- NVEI $1,359,722,000.00
- Revenue This Year
- KRYS $485.65
- NVEI $18.83
- Revenue Next Year
- KRYS $58.64
- NVEI $15.63
- P/E Ratio
- KRYS $100.04
- NVEI $215.51
- Revenue Growth
- KRYS 2722.80
- NVEI 24.89
- 52 Week Low
- KRYS $96.73
- NVEI $19.07
- 52 Week High
- KRYS $219.34
- NVEI $33.99
- Technical
- Relative Strength Index (RSI)
- KRYS 42.62
- NVEI 72.36
- Support Level
- KRYS $182.26
- NVEI $33.42
- Resistance Level
- KRYS $207.84
- NVEI $33.70
- Average True Range (ATR)
- KRYS 8.55
- NVEI 0.12
- MACD
- KRYS -0.10
- NVEI 0.04
- Stochastic Oscillator
- KRYS 20.00
- NVEI 99.23
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About NVEI Nuvei Corporation Subordinate Voting Shares
Nuvei Corp is a provider of payment technology solutions to merchants and partners. The solutions provided are mobile payments, online payments, and In-store payments. Its geographical segments are North America; Europe, the Middle East, and Africa; Latin America; and the Asia Pacific. The vast majority of the company's revenue is generated from North America and EMEA.